TrialCancer research communications2024

High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial.

Channing J Paller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.